Developer docs
API playgroundTry for free, no card

Search company profiles

Orygen

Full company profile

uuid000e3ns

Namestring
Orygen
Legal namestring
Orygen Limited
Websiteurl
orygen.org.au
Company typeenum
Private
Founded yearint
1992
Descriptiontext

Orygen is Australia's National Centre of Excellence in Youth Mental Health, operating as a not-for-profit company limited by guarantee headquartered in Parkville, Melbourne. Founded in 1984 as a first-episode psychosis research unit at Royal Park Hospital and formalized through the 1992 founding of the Early Psychosis Prevention and Intervention Centre (EPPIC), Orygen now operates an integrated portfolio spanning clinical care, translational research, policy advocacy, and professional education. Its clinical footprint includes five headspace centres in north and north-west Melbourne (Glenroy, Sunshine, Craigieburn, Melton, Werribee), the Parkville Youth Mental Health and Wellbeing Service (PYMHWS, launched 1 July 2025 from the former Orygen Specialist Program), the Orygen Recovery (YPARC) psychosocial program, and the Orygen Assist essential-items support program. Specialized programs include #chatsafe (world-first online suicide prevention guidelines), the Australian Early Psychosis Program (AEPP), the Youth Enhanced Services (YES) Hub, and Orygen Global for international capacity building.

The technology stack combines digital mental health interventions, AI-powered personalized care (under a $5.7M Wellcome-funded build-out), virtual reality therapy through the Orygen Digital XR Innovation Lab, and a Learning Management System (LMS) hosting online training modules and certificates such as the Certificate IV in Mental Health Peer Work, the Graduate Mental Health Nurse Program, and the Professional Certificate in Youth Psychiatry. Proprietary platforms include the AEPP Hub and YES Hub for Primary Health Networks, the CAARMS 23 clinical assessment toolkit, and the Youth Partnerships in Research Toolkit. The organization maintains a 35-strong research leadership team across psychosis, mood disorders, trauma, eating disorders, neurodevelopment, cognition, substance use, men's mental health, and implementation science.

Orygen's revenue model is a multi-stream non-profit structure: government funding (Australian Department of Health and Primary Health Networks for headspace and PYMHWS), charitable donations (Deductible Gift Recipient, ABN 85 098 918 686), and fee-for-service training and education. Clinical services are delivered free to young people aged 12-25. Distribution runs through direct clinical operations (headspace, PYMHWS), the LMS for professional self-serve training, and Orygen Global for international advisory. Strategic positioning is reinforced by its designation as the world's first WHO Collaborating Centre for Young People's Mental Health and its role in founding the national headspace network in 2006.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
251–500
akta.pro rankint
HeadquartersMelbourne, Australia
HQ citystring
Melbourne
HQ countrystring
Australia
HQ regionstring
Oceania
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
youth mental health, clinical mental health services, mental health research, psychosis early intervention, mental health education
Industry1 code
1Behavioral Health & Psychiatry Virtual Care (Payer Network)
CodeHLALACACPrimaryYes
NAICS code1 code
  • Outpatient Mental Health and Substance Abuse Centers621420
SIC code1 code
  • Services-Offices & Clinics Of Doctors Of Medicine8011
Product category
Youth Mental Health Services
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model3 records
1Government Funding
TypeManaged Services
Description

Orygen is funded by the Australian Government Department of Health and receives contracted services from the Australian Government for supporting commissioning and implementation of primary care mental health services.

rto.orygen.org.au
2Donations and Philanthropy
TypeGrants Donations
Description

Charitable donations from individuals and organizations. Orygen is a deductible gift recipient (ABN 85 098 918 686), accepting donations through online platforms.

orygen.org.au
3Training and Education Services
TypeProfessional Services
Description

Fees for professional certificates, graduate courses, specialist training programs for psychiatric registrars, and online training sessions for professionals.

orygen.org.au
Marketing channels9 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels5 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure
Pricing details1 tier
1Free clinical services for young people
ModelOtherBilling cadenceOther
Notes

Clinical services are provided free of charge through headspace centres and Orygen's clinical programs for young people aged 12-25 experiencing mental ill-health.

orygen.org.au
GTM typeB2B and B2C
B2B and B2C
Offering typeServices
Services
Brand1 of 4 records shown
1#chatsafe
Description

World-first suicide prevention program that empowers young people to communicate safely online about self-harm and suicide

lms.orygen.org.au
+3 more records
Core offering1 text field

Orygen is Australia's National Centre of Excellence in Youth Mental Health, operating as a not-for-profit organization that delivers youth mental health clinical care, research, policy development, and education. It operates headspace centres in north-west Melbourne, the Parkville Youth Mental Health and Wellbeing Service, and offers professional training programs through its Learning Management System. The organization also runs specialized programs including #chatsafe (suicide prevention), Orygen Assist (essential items support), and Orygen Global (international capacity building).

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 2 values shown
  • Cannabis use declined by 10% in young people receiving early psychosis intervention
+1 more record
Product overview1 text field

Orygen is Australia's National Centre of Excellence in Youth Mental Health, operating as a not-for-profit organization. The organization offers a comprehensive portfolio spanning clinical care, research, education, and policy. Core clinical services include headspace centres across north-west Melbourne providing youth mental health services, the Parkville Youth Mental Health and Wellbeing Service (PYMHWS), and the Australian Early Psychosis Program (AEPP). Education offerings include a Learning Management System (LMS) delivering vocational certificates, graduate programs, and professional training for mental health workers. Specialized programs include #chatsafe (suicide prevention), Orygen Assist (essential items support), Youth Enhanced Services (YES) Hub for PHNs, and Orygen Global for international capacity building. The organization is structured as a not-for-profit company limited by guarantee with charitable status and approved research institute designation.

Product and service13 records
1#chatsafe
CategorySuicide prevention program
Description

A world-first suicide prevention program that empowers young people to communicate safely online about self-harm and suicide, providing evidence-backed advice for young people, their supporters, and communities.

2headspace Centres (Glenroy, Sunshine, Craigieburn, Melton, Werribee)
CategoryClinical mental health service
Description

Clinical services operated by Orygen in north and north-west Melbourne providing youth mental health care through headspace centres. Free for young people aged 12-25.

3Australian Early Psychosis Program (AEPP)
CategoryNational mental health program
Description

National program promoting development and establishment of early psychosis services, supporting headspace Early Psychosis programs with technical advice, workshops, and resources.

4Youth Enhanced Services (YES) Hub
CategoryProfessional training platform
Description

Online platform providing PHNs and service providers access to youth enhanced resources, discussion forums, and 23 free online training modules.

5CHC43515 Certificate IV in Mental Health Peer Work
CategoryEducation program
Description

Registered training qualification in mental health peer work for consumer peer workers, delivered through Orygen RTO.

6Graduate Mental Health Nurse Program
CategoryEducation program
Description

Specialized training program for graduate nurses in youth mental health.

7Professional Certificate in Youth Psychiatry
CategoryProfessional development program
Description

Professional development certificate for psychiatrists specializing in youth mental health.

8Orygen Assist
CategorySupport program
Description

Volunteer-run program providing free essential items such as food, clothing, and hygiene products to young people experiencing mental ill-health at seven sites around Melbourne.

9Learning Management System (LMS)
CategoryDigital education platform
Description

Online training platform for delivering education programs, managing student enrollment, and providing training resources to health professionals.

10CAARMS 23 Toolkit
CategoryClinical assessment tool
Description

Clinical assessment resource for psychosis research and diagnosis.

11Orygen Global
CategoryInternational consulting and advocacy
Description

International division providing advice and advocacy for youth mental health globally, supporting organizations in implementing youth mental health services.

12Parkville Youth Mental Health and Wellbeing Service (PYMHWS)
CategoryClinical mental health service
Description

Specialized youth mental health and wellbeing clinical service (formerly Orygen Specialist Program), located in Parkville.

13Orygen Recovery (YPARC)
CategoryClinical recovery program
Description

Psychosocial recovery program for young people with mental ill-health.

Scale indicator9 records

Each record includes

Type, Value, Description, Source

Partnership9 partners
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-02-11
Description

Partnership for Phase 2 investigator-initiated trial studying DB103 (pomaglumetad methionil) for first-episode psychosis and clinical high risk of psychosis. Led by Professor Patrick McGorry and sponsored by Orygen in Parkville, Australia. The 12-week open-label trial evaluates safety, tolerability, and efficacy in patients aged 18-25.

Strategic tierCoreTypeGTM or Marketing Partner
Description

AFL PLAY and Orygen partnered to connect young people and their families with trusted, evidence-based mental health support beyond the sporting field.

Strategic tierSupportingTypeStrategic or Co-development Partner
Description

Charity partner supporting Orygen Assist program that provides essential items to young people experiencing mental ill-health.

Strategic tierSupportingTypeStrategic or Co-development Partner
Description

Charity partner providing clothing and essential items for Orygen Assist program.

5Pinchapoo
Strategic tierSupportingTypeStrategic or Co-development Partner
Description

Charity partner supporting Orygen Assist with hygiene products and essential items.

orygen.org.au
6Rotary Central Melbourne
Strategic tierSupportingTypeStrategic or Co-development Partner
Description

Charity partner supporting Orygen Assist volunteer program.

orygen.org.au
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Successful partnership resulted in the publication of a Global Framework for Youth Mental Health, leading to the launch of Orygen Global in 2020.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Partners since April 2022, Orygen and Victoria University are growing the workforce of youth mental health professionals through education and training programs.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Long-standing partnership with University of Melbourne for research and clinical operations. The Colonial Foundation and University of Melbourne supported the purpose-built Parkville facility.

Recent move12 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Australian not-for-profit medical research institute focused on mental health and translational research; directly comparable as a fellow Australian research-to-clinical NFP working across mood disorders, suicide prevention and digital interventions.

TypeDirect peer
Description

National youth mental health foundation that Orygen was instrumental in founding; operates a parallel network of youth mental health centres across Australia delivering similar early-intervention services to the same 12-25 demographic.

TypeDirect peer
Description

Australia's largest mental health NFP, providing 24/7 support, information and research funding; comparable to Orygen as an Australian mental health research, support and advocacy organisation targeting anxiety, depression and suicide prevention.

TypeDirect peer
Description

University-hosted mental health and neuroscience research centre delivering clinical services and translational research; directly comparable as a translational youth/adult mental health research-clinical entity based in Sydney.

TypeDirect peer
Description

Australian NFP focused on complex mental illness, research, advocacy and peer support; comparable to Orygen as a mental health research and advocacy NFP serving people with severe or persistent mental health conditions.

TypeDirect peer
Description

One of Australia's largest community-managed mental health organisations providing clinical and psychosocial support services; comparable as a fellow Australian mental health NFP operating service delivery alongside advocacy and research.

TypeDirect peer
Description

UK charity dedicated to children and young people's mental health, combining research, campaigning and direct services; comparable to Orygen as a peer-country organisation focused exclusively on youth mental health research, policy and support.

TypeBroad incumbent
Description

Canada's largest mental health and addiction teaching hospital and research institute; comparable to Orygen as a much larger peer mental health research-clinical enterprise, though broader in scope (all ages, hospital-based) than Orygen's youth focus.

9Bateman Centre for Mental Health Research and Translation
TypeEmerging player
Description

Australian emerging mental health research centre applying translational research models; comparable to Orygen's translational research role but at an earlier stage of scale and brand recognition.

TypeDirect peer
Description

Australian NFP that originated the global Mental Health First Aid training program; directly comparable as an Australian mental health education and training NFP with international scaling, mirroring Orygen's training and education revenue stream.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks7 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers3 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI capability3 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature5 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles12 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries6 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Orygen

Youth Mental Health Servicesorygen.org.au

What Orygen does

Orygen is Australia's National Centre of Excellence in Youth Mental Health, operating as a not-for-profit company limited by guarantee headquartered in Parkville, Melbourne. Founded in 1984 as a first-episode psychosis research unit at Royal Park Hospital and formalized through the 1992 founding of the Early Psychosis Prevention and Intervention Centre (EPPIC), Orygen now operates an integrated portfolio spanning clinical care, translational research, policy advocacy, and professional education. Its clinical footprint includes five headspace centres in north and north-west Melbourne (Glenroy, Sunshine, Craigieburn, Melton, Werribee), the Parkville Youth Mental Health and Wellbeing Service (PYMHWS, launched 1 July 2025 from the former Orygen Specialist Program), the Orygen Recovery (YPARC) psychosocial program, and the Orygen Assist essential-items support program. Specialized programs include #chatsafe (world-first online suicide prevention guidelines), the Australian Early Psychosis Program (AEPP), the Youth Enhanced Services (YES) Hub, and Orygen Global for international capacity building.

The technology stack combines digital mental health interventions, AI-powered personalized care (under a $5.7M Wellcome-funded build-out), virtual reality therapy through the Orygen Digital XR Innovation Lab, and a Learning Management System (LMS) hosting online training modules and certificates such as the Certificate IV in Mental Health Peer Work, the Graduate Mental Health Nurse Program, and the Professional Certificate in Youth Psychiatry. Proprietary platforms include the AEPP Hub and YES Hub for Primary Health Networks, the CAARMS 23 clinical assessment toolkit, and the Youth Partnerships in Research Toolkit. The organization maintains a 35-strong research leadership team across psychosis, mood disorders, trauma, eating disorders, neurodevelopment, cognition, substance use, men's mental health, and implementation science.

Orygen's revenue model is a multi-stream non-profit structure: government funding (Australian Department of Health and Primary Health Networks for headspace and PYMHWS), charitable donations (Deductible Gift Recipient, ABN 85 098 918 686), and fee-for-service training and education. Clinical services are delivered free to young people aged 12-25. Distribution runs through direct clinical operations (headspace, PYMHWS), the LMS for professional self-serve training, and Orygen Global for international advisory. Strategic positioning is reinforced by its designation as the world's first WHO Collaborating Centre for Young People's Mental Health and its role in founding the national headspace network in 2006.

Orygen firmographics

Firmographics
Name
Orygen
Legal name
Orygen Limited
Website
https://orygen.org.au
Company type
Private
Founded year
1992
Operating status
Operating
Headcount range
251–500 employees
Ownership category
akta.pro rank

Orygen industry classification

Industry
Product category
Youth Mental Health Services
NAICS
Outpatient Mental Health and Substance Abuse Centers (621420)
SIC
Services-Offices & Clinics Of Doctors Of Medicine (8011)
akta.pro primary industry
Behavioral Health & Psychiatry Virtual Care (Payer Network) (HLALACAC)

Keywords

  • Youth mental health
  • Clinical mental health services
  • Mental health research
  • Psychosis early intervention
  • Mental health education

Where Orygen is headquartered

Location

Headquarters

HQ city
Melbourne
HQ country
Australia
HQ region
Oceania

Offices1 record

Markets served

Orygen business model

Business model
GTM type
B2B and B2C
Offering type
Services
Cost components
Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

  1. Government Funding: Orygen is funded by the Australian Government Department of Health and receives contracted services from the Australian Government for supporting commissioning and implementation of primary care mental health services.
  2. Donations and Philanthropy: Charitable donations from individuals and organizations. Orygen is a deductible gift recipient (ABN 85 098 918 686), accepting donations through online platforms.
  3. Training and Education Services: Fees for professional certificates, graduate courses, specialist training programs for psychiatric registrars, and online training sessions for professionals.

Pricing tiers

ModelBillingPrice
OtherOtherFree clinical services for young people

Go-to-market motion2 records

Distribution channels5 records

Marketing channels9 records

Orygen product offering

Product offering

Core offering

Orygen is Australia's National Centre of Excellence in Youth Mental Health, operating as a not-for-profit organization that delivers youth mental health clinical care, research, policy development, and education. It operates headspace centres in north-west Melbourne, the Parkville Youth Mental Health and Wellbeing Service, and offers professional training programs through its Learning Management System. The organization also runs specialized programs including #chatsafe (suicide prevention), Orygen Assist (essential items support), and Orygen Global (international capacity building).

Product overview

Orygen is Australia's National Centre of Excellence in Youth Mental Health, operating as a not-for-profit organization. The organization offers a comprehensive portfolio spanning clinical care, research, education, and policy. Core clinical services include headspace centres across north-west Melbourne providing youth mental health services, the Parkville Youth Mental Health and Wellbeing Service (PYMHWS), and the Australian Early Psychosis Program (AEPP). Education offerings include a Learning Management System (LMS) delivering vocational certificates, graduate programs, and professional training for mental health workers. Specialized programs include #chatsafe (suicide prevention), Orygen Assist (essential items support), Youth Enhanced Services (YES) Hub for PHNs, and Orygen Global for international capacity building. The organization is structured as a not-for-profit company limited by guarantee with charitable status and approved research institute designation.

Differentiator

Problem solved

Functional benefit

Brands

  • #chatsafe: World-first suicide prevention program that empowers young people to communicate safely online about self-harm and suicide
  • Australian Early Psychosis Program (AEPP)
  • Orygen Assist
  • EPPIC

Products and services

  • #chatsafe A world-first suicide prevention program that empowers young people to communicate safely online about self-harm and suicide, providing evidence-backed advice for young people, their supporters, and communities.
  • headspace Centres (Glenroy, Sunshine, Craigieburn, Melton, Werribee) Clinical services operated by Orygen in north and north-west Melbourne providing youth mental health care through headspace centres. Free for young people aged 12-25.
  • Australian Early Psychosis Program (AEPP) National program promoting development and establishment of early psychosis services, supporting headspace Early Psychosis programs with technical advice, workshops, and resources.
  • Youth Enhanced Services (YES) Hub Online platform providing PHNs and service providers access to youth enhanced resources, discussion forums, and 23 free online training modules.
  • CHC43515 Certificate IV in Mental Health Peer Work Registered training qualification in mental health peer work for consumer peer workers, delivered through Orygen RTO.
  • Graduate Mental Health Nurse Program Specialized training program for graduate nurses in youth mental health.
  • Professional Certificate in Youth Psychiatry Professional development certificate for psychiatrists specializing in youth mental health.
  • Orygen Assist Volunteer-run program providing free essential items such as food, clothing, and hygiene products to young people experiencing mental ill-health at seven sites around Melbourne.
  • Learning Management System (LMS) Online training platform for delivering education programs, managing student enrollment, and providing training resources to health professionals.
  • CAARMS 23 Toolkit Clinical assessment resource for psychosis research and diagnosis.
  • Orygen Global International division providing advice and advocacy for youth mental health globally, supporting organizations in implementing youth mental health services.
  • Parkville Youth Mental Health and Wellbeing Service (PYMHWS) Specialized youth mental health and wellbeing clinical service (formerly Orygen Specialist Program), located in Parkville.
  • Orygen Recovery (YPARC) Psychosocial recovery program for young people with mental ill-health.

Quantifiable outcome

  • Cannabis use declined by 10% in young people receiving early psychosis intervention
  • +1 more outcomes

Companies that use Orygen

Customer profile

Named customers3 records

Segments4 records

Ideal customer profiles3 records

Orygen technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability3 records

Feature5 records

Orygen partnerships and signals

Strategic signal

Partnerships

Nine partnerships are on record, tiered core and supporting.

  • Denovo BiopharmacoreStrategic or Co-development Partner · 11 February 2026Partnership for Phase 2 investigator-initiated trial studying DB103 (pomaglumetad methionil) for first-episode psychosis and clinical high risk of psychosis. Led by Professor Patrick McGorry and sponsored by Orygen in Parkville, Australia. The 12-week open-label trial evaluates safety, tolerability, and efficacy in patients aged 18-25.
  • AFL PLAYcoreGTM or Marketing PartnerAFL PLAY and Orygen partnered to connect young people and their families with trusted, evidence-based mental health support beyond the sporting field.
  • Foodbank VictoriasupportingStrategic or Co-development PartnerCharity partner supporting Orygen Assist program that provides essential items to young people experiencing mental ill-health.
  • Thread TogethersupportingStrategic or Co-development PartnerCharity partner providing clothing and essential items for Orygen Assist program.
  • PinchapoosupportingStrategic or Co-development PartnerCharity partner supporting Orygen Assist with hygiene products and essential items.
  • Rotary Central MelbournesupportingStrategic or Co-development PartnerCharity partner supporting Orygen Assist volunteer program.
  • World Economic ForumcoreStrategic or Co-development PartnerSuccessful partnership resulted in the publication of a Global Framework for Youth Mental Health, leading to the launch of Orygen Global in 2020.
  • Victoria UniversitycoreStrategic or Co-development PartnerPartners since April 2022, Orygen and Victoria University are growing the workforce of youth mental health professionals through education and training programs.
  • University of MelbournecoreStrategic or Co-development PartnerLong-standing partnership with University of Melbourne for research and clinical operations. The Colonial Foundation and University of Melbourne supported the purpose-built Parkville facility.

Scale indicators9 records

Recent moves12 records

Expansion highlights6 records

Orygen competitors and assessment

Company assessment

Direct peers

  • Black Dog Institute: Australian not-for-profit medical research institute focused on mental health and translational research; directly comparable as a fellow Australian research-to-clinical NFP working across mood disorders, suicide prevention and digital interventions.
  • headspace National Youth Mental Health Foundation: National youth mental health foundation that Orygen was instrumental in founding; operates a parallel network of youth mental health centres across Australia delivering similar early-intervention services to the same 12-25 demographic.
  • Beyond Blue: Australia's largest mental health NFP, providing 24/7 support, information and research funding; comparable to Orygen as an Australian mental health research, support and advocacy organisation targeting anxiety, depression and suicide prevention.
  • Brain and Mind Centre (University of Sydney): University-hosted mental health and neuroscience research centre delivering clinical services and translational research; directly comparable as a translational youth/adult mental health research-clinical entity based in Sydney.
  • SANE Australia: Australian NFP focused on complex mental illness, research, advocacy and peer support; comparable to Orygen as a mental health research and advocacy NFP serving people with severe or persistent mental health conditions.
  • Mind Australia: One of Australia's largest community-managed mental health organisations providing clinical and psychosocial support services; comparable as a fellow Australian mental health NFP operating service delivery alongside advocacy and research.
  • YoungMinds (UK): UK charity dedicated to children and young people's mental health, combining research, campaigning and direct services; comparable to Orygen as a peer-country organisation focused exclusively on youth mental health research, policy and support.
  • Mental Health First Aid Australia: Australian NFP that originated the global Mental Health First Aid training program; directly comparable as an Australian mental health education and training NFP with international scaling, mirroring Orygen's training and education revenue stream.

Broad incumbents

  • Centre for Addiction and Mental Health (CAMH): Canada's largest mental health and addiction teaching hospital and research institute; comparable to Orygen as a much larger peer mental health research-clinical enterprise, though broader in scope (all ages, hospital-based) than Orygen's youth focus.

Emerging players

  • Bateman Centre for Mental Health Research and Translation: Australian emerging mental health research centre applying translational research models; comparable to Orygen's translational research role but at an earlier stage of scale and brand recognition.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks7 records

Key highlights7 records

Customer concentration

Orygen social profiles

Digital presence

Orygen financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Orygen leadership team

Management profile

Number of profiles

Profiles12 records

Orygen subsidiaries and ownership

Company hierarchy

Subsidiaries6 records

Orygen funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Orygen M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Orygen

What does Orygen do?

Orygen is Australia's National Centre of Excellence in Youth Mental Health, operating as a not-for-profit organization that delivers youth mental health clinical care, research, policy development, and education. It operates headspace centres in north-west Melbourne, the Parkville Youth Mental Health and Wellbeing Service, and offers professional training programs through its Learning Management System. The organization also runs specialized programs including #chatsafe (suicide prevention), Orygen Assist (essential items support), and Orygen Global (international capacity building).

Is Orygen a public or private company?

Orygen is a private company. It is classified as nonprofit foundation owned and is currently operating.

When was Orygen founded?

Orygen was founded in 1992. It employs 251 to 500 people.

Where is Orygen based?

Orygen is headquartered in Melbourne, Australia, in the Oceania region.

How does Orygen make money?

Three revenue lines are on record. Government Funding is the primary driver. The others are donations and Philanthropy and training and Education Services.

Who are Orygen's main competitors?

Direct peers on record are Black Dog Institute, headspace National Youth Mental Health Foundation, Beyond Blue, Brain and Mind Centre (University of Sydney), SANE Australia, Mind Australia, YoungMinds (UK) and Mental Health First Aid Australia. Centre for Addiction and Mental Health (CAMH) is listed as a broad incumbent. Bateman Centre for Mental Health Research and Translation is listed as an emerging player.

Does Orygen have an API?

No public API is recorded for Orygen.

What industry is Orygen in?

Orygen's product category is Youth Mental Health Services. Its primary akta.pro industry code is HLALACAC, Behavioral Health & Psychiatry Virtual Care (Payer Network). Its NAICS code is 621420 and its SIC code is 8011.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
The AustralianYoung homeless in Victoria forced into hospital during mental health crisis, report findsMelbourne City Mission released data on Monday revealing that over half of young people accessing homelessness services in Victoria had attended hospital emergency departments for mental health concerns, with nearly 60 percent having self-harmed, experienced suicidal thoughts, or attempted suicide. The survey of 209 young people aged 15 to 24 found that most had grown up experiencing family violence, and many had been homeless for extended periods. The data prompted Melbourne City Mission and Orygen to call on Victoria's incoming government to commit to a dedicated supported-housing model for young people as a form of mental health intervention, citing the current system as broken and failing vulnerable youth.ABCPolice investigating machete attack at Sunshine youth mental health clinicFour masked men attacked two 19-year-old patients with machetes at a youth mental health clinic in Sunshine, Melbourne on Tuesday afternoon, though neither victim was physically injured. Staff from Parkville Youth Mental Health and Wellbeing Service have been directed to work off-site following the violence, which follows a series of prior assaults on workers at the service. The Health and Community Services Union has backed the decision to relocate staff and criticized the response from Headspace, which is operated by Orygen within the Visy Cares Hub.EIN PresswireGlobal Health Leaders Call for Suicide Prevention to be Embedded in AI Chatbots and Online Safety PolicyGlobal health leaders are calling for suicide prevention to be embedded in AI chatbots and online safety policy. A side event at WHA79 on 20 May 2026 will examine how AI and social media platforms can be designed and governed to protect vulnerable people. The event aims to provide input for delegations at WHA79.IpeActis exits Orygen, one of Peru’s largest power producersActis, a growth market investor in sustainable infrastructure, has completed the sale of Orygen, Peru's second-largest power generation platform with 2.3GW of installed capacity, to Grupo Romero, one of Peru's most prominent financial and industrial conglomerates. The transaction marks Actis's exit from Orygen, which was launched in 2024 after being carved out from Enel. During Actis's ownership, Orygen strengthened its position as Peru's largest renewables portfolio through digital transformation and strategic repositioning initiatives.GlobeNewswireDenovo Biopharma Announces Partnership with Orygen on Phase 2 Study Evaluating DB103 (Pomaglumetad Methionil) in Treating PsychosisDenovo Biopharma announced a partnership with Orygen to initiate a Phase 2 investigator-initiated trial studying DB103 (pomaglumetad methionil) for treating first-episode psychosis and clinical high risk of psychosis in young patients aged 18-25. The 12-week, open-label trial will evaluate the safety, tolerability, and efficacy of twice-daily 40mg doses in patients who have shown insufficient response to first-line antipsychotic treatments. DB103, a first-in-class glutamate-targeting drug licensed from Eli Lilly, previously showed promise in early-stage disease subsets despite failing in broad schizophrenia studies.GlobeNewswireDenovo Biopharma Announces Partnership with Orygen on Phase 2 Study Evaluating DB103 (Pomaglumetad Methionil) in Treating PsychosisDenovo Biopharma announced a partnership with Orygen to initiate a Phase 2 investigator-initiated-trial studying DB103 (pomaglumetad methionil) for first-episode psychosis or clinical high risk of psychosis, to be led by Professor Patrick McGorry and sponsored by Orygen in Parkville, Australia. The open-label, 12-week feasibility trial will evaluate safety, tolerability, and efficacy of twice-daily 40 mg doses in patients aged 18-25 with insufficient response to first-line antipsychotics. The drug, licensed from Eli Lilly after 37 prior clinical trials involving over 3,800 subjects, targets the glutamate system and represents a potential treatment option for an unmet medical need in youth mental health.YahooDenovo Biopharma Announces Partnership with Orygen on Phase 2 Study Evaluating DB103 (Pomaglumetad Methionil) in Treating PsychosisDenovo Biopharma announced a partnership with Orygen to initiate a Phase 2 investigator-initiated trial studying DB103 (pomaglumetad methionil) for first-episode psychosis and clinical high risk of psychosis in young patients aged 18-25. The open-label trial will evaluate safety, tolerability, and acceptability of the drug over 12 weeks in patients who have shown insufficient response to first-line antipsychotic treatments. The drug, licensed from Eli Lilly, represents a first-in-class treatment targeting the glutamate system to address unmet medical needs in psychiatric care.BioSpaceDenovo Biopharma Announces Partnership with Orygen on Phase 2 Study Evaluating DB103 (Pomaglumetad Methionil) in Treating PsychosisDenovo Biopharma announced a partnership with Orygen to initiate a Phase 2 investigator-initiated trial evaluating DB103 (pomaglumetad methionil) for treating first-episode psychosis and clinical high risk of psychosis in young people aged 18-25 in Australia. The 12-week open-label feasibility study will investigate safety, tolerability, and acceptability of the drug, which was licensed from Eli Lilly after the original developer completed 37 clinical trials with over 3,800 subjects. This trial focuses on a glutamate-targeting mechanism that may address unmet medical needs unmet by current antipsychotics.MobiHealthNews$9M funding to power mental health with AI and more briefsYouth mental health organization Orygen and the University of Melbourne secured A$14 million ($9 million) in funding from Wellcome to develop an AI-enabled digital mental health platform. The project will enhance Orygen's existing Moderated Online Social Therapy platform, adapting it for international deployment in the Netherlands, Germany, and Spain. Additionally, Lumonus has raised A$25 million ($17 million) in a Series B funding round to support expansion and development of its oncology software.GlobeNewswirePharmAla Biotech Completes Release Testing on Australian-Made LaNeo CapsulesPharmAla Biotech Holdings Inc. announced the completion of release testing on its first Australian-made batch of LaNeo MDMA 40mg capsules, manufactured in partnership with Cortexa. The company also completed its final delivery of Australian-made product to the Orygen Institute, concluding its contract to support Orygen's Phase 3 Trial examining social anxiety in autistic youth. PharmAla has outlined an active production schedule for 2026, including development of 20mg capsules and manufacture of ALA-002 capsules.